Verani M S
Section of Cardiology, Baylor College of Medicine, Houston, TX 77030, USA.
J Nucl Cardiol. 1997 Mar-Apr;4(2 Pt 2):S158-63. doi: 10.1016/s1071-3581(97)90095-7.
Nuclear cardiology offers techniques for assessing cardiac perfusion and function that provide useful information for diagnosing and managing acute myocardial infarction (MI). In particular, myocardial perfusion imaging provides important data on infarct size and myocardial viability that can help determine the best treatment strategies for patients with acute MI. First-pass or blood pool radionuclide angiographic assessment of ventricular ejection fraction remains an important prognostic indicator in acute MI, regardless of whether thrombolytic therapy is used. Comparative studies of radiotracer techniques and coronary angiography show that myocardial perfusion and ejection fraction can predict the risk of future cardiac events reliably in patients with acute MI, whereas the anatomic data provided by coronary angiography (e.g., degree of stenosis and presence of multivessel disease) have little prognostic value. Managed-care organizations could reduce costs and improve patient outcomes by relying more on nuclear cardiology and less on angiography in the management of patients' with acute MI.
核心脏病学提供了评估心脏灌注和功能的技术,这些技术为诊断和管理急性心肌梗死(MI)提供了有用信息。特别是,心肌灌注成像提供了有关梗死面积和心肌存活性的重要数据,有助于确定急性心肌梗死患者的最佳治疗策略。无论是否使用溶栓治疗,首次通过或血池放射性核素血管造影评估心室射血分数仍然是急性心肌梗死的重要预后指标。放射性示踪剂技术与冠状动脉造影的比较研究表明,心肌灌注和射血分数能够可靠地预测急性心肌梗死患者未来发生心脏事件的风险,而冠状动脉造影提供的解剖学数据(如狭窄程度和多支血管病变的存在)的预后价值很小。管理式医疗组织在管理急性心肌梗死患者时,更多地依靠核心脏病学,减少对血管造影的依赖,可降低成本并改善患者预后。